Cartesian Therapeutics, Inc. Stock Forecast
A very red day for Cartesian Therapeutics, Inc. stock price after a -5.29% fall in the Friday trading session
(Updated on Jun 28, 2024)
The Cartesian Therapeutics, Inc. stock price fell by -5.29% on the last day (Friday, 28th Jun 2024) from $28.52 to $27.01. During the last trading day the stock fluctuated 8.62% from a day low at $26.10 to a day high of $28.35. The price has been going up and down for this period, and there has been a -7.78% loss for the last 2 weeks. Volume has increased on the last day by 362 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 498 thousand shares were bought and sold for approximately $13.45 million.
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 59.36% during the next 3 months and, with a 90% probability hold a price between $37.35 and $63.65 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
RNAC Signals & Forecast
There are few to no technical positive signals at the moment. The Cartesian Therapeutics, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $27.57. On a fall, the stock will find some support from the short-term average at $24.72. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Friday, June 07, 2024, and so far it has fallen -26.16%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Support, Risk & Stop-loss for Cartesian Therapeutics, Inc. stock
On the downside, the stock finds support just below today's level from accumulated volume at $24.75 and $24.60. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Cartesian Therapeutics, Inc. finds support just below today's level at $24.75. If this is broken, then the next support from accumulated volume will be at $24.60 and $22.00.
This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $2.25 between high and low, or 8.62%. For the last week, the stock has had daily average volatility of 13.98%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (RNAC) For The Upcoming Trading Day Of Monday 1st
For the upcoming trading day on Monday, 1st we expect Cartesian Therapeutics, Inc. to open at $27.15, and during the day (based on 14 day Average True Range), to move between $23.73 and $30.29, which gives a possible trading interval of +/-$3.28 (+/-12.14%) up or down from last closing price. If Cartesian Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 24.27% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $27.29 (1.04%) than the support at $24.75 (8.37%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Cartesian Therapeutics, Inc. stock A Buy?
The Cartesian Therapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe Cartesian Therapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.
Current score: -4.480 Sell Candidate Downgraded
Predicted Opening Price for Cartesian Therapeutics, Inc. of Monday, July 1, 2024
| Fair opening price July 1, 2024 | Current price |
|---|---|
| $27.15 ( 0.531%) | $27.01 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for RNAC
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 29.40 | 8.86% |
| R2 | 28.54 | 5.68% |
| R1 | 28.01 | 3.71% |
| Price | 27.01 | |
| S1 | 26.29 | -2.65% |
| S2 | 25.76 | -4.62% |
| S3 | 24.90 | -7.80% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 28.52 | 5.59% |
| R2 | 28.26 | 4.63% |
| R1 | 27.29 | 1.04% |
| Price | 27.01 | |
| S1 | 24.75 | -8.37% |
| S2 | 24.60 | -8.92% |
| S3 | 22.00 | -18.55% |
FAQ
Click here for our free guide on how to buy Cartesian Therapeutics, Inc. Stock.
